Hong Kong Real Estate Stock News

In the past week, InnoCare Pharma reported China NMPA approval of zurletrectinib (ICP-723) for NTRK fusion-positive solid tumors in patients aged 12 and above, alongside strong efficacy and safety data, while also showcasing extensive positive clinical results for orelabrutinib and mesutoclax at the ASH 67th Annual Meeting. This marks InnoCare’s first approved solid-tumor therapy, adding a blood–brain-barrier-penetrant TRK inhibitor to its portfolio and underscoring its push to build a broad...

CStone Pharmaceuticals announced that its RET-targeted cancer therapy GAVRETO® (pralsetinib) has been approved for inclusion in China’s National Reimbursement Drug List, with reimbursement due to begin on 1 January 2026. This listing materially broadens patient access in China’s public healthcare system, potentially reinforcing CStone’s role as a key oncology player in Greater China. We’ll now examine how NRDL inclusion for GAVRETO shapes CStone’s investment narrative, particularly around...

If you are wondering whether BYD is still a smart buy at today’s price, or if the big gains are mostly behind it, this article will walk through what the current market is really pricing in. After a 14.4% gain year to date and a 46.5% climb over 3 years, the recent 2.0% pullback over the last month suggests sentiment is cooling a bit, but not necessarily the long term story. Investors have been reacting to a mix of headlines around global EV competition, shifting subsidies in China, and...

You may think that with a price-to-sales (or "P/S") ratio of 0.2x Enviro Energy International Holdings Limited...

Key Insights Significant insider control over ZG Group implies vested interests in company growth The top 5...

Key Insights The considerable ownership by private equity firms in Xiamen Yan Palace Bird's Nest Industry indicates...

Feiyang International Holdings Group Limited ( HKG:1901 ) shareholders would be excited to see that the share price has...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

From what we can see, insiders were net sellers in China Youran Dairy Group Limited's ( HKG:9858 ) during the past 12...

With a median price-to-sales (or "P/S") ratio of close to 0.8x in the Hospitality industry in Hong Kong, you could be...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

With a median price-to-sales (or "P/S") ratio of close to 0.5x in the Basic Materials industry in Hong Kong, you could...

It is hard to get excited after looking at Great Wall Motor's (HKG:2333) recent performance, when its stock has...

YesAsia Holdings Limited's (HKG:2209) stock price has dropped 11% in the previous week, but insiders who sold US$5.0m...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Winfair...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 13x, you may consider...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Shareholders appeared to be happy with DYNAM JAPAN HOLDINGS Co., Ltd.'s ( HKG:6889 ) solid earnings report last week...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Niraku GC Holdings, Inc.'s ( HKG:1245 ) strong earnings report was rewarded with a positive stock price move. Our...